According to a market report by Lucintel, the future of the global cephalosporin market looks promising with opportunities in the first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth-generation cephalosporin markets. The global cephalosporin market is expected to reach an estimated $18 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are growing prevalence of infectious diseases, rise in R&D activities for the development of combination drugs, and increase in funding for the development of antibiotics.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in cephalosporin market to 2030 by type (branded and
generic), route of administration (intravenous and oral), generation (first-generation
cephalosporin, second-generation cephalosporin, third-generation cephalosporin,
fourth-generation cephalosporin, and fifth-generation cephalosporin),
application (respiratory tract infection, skin infection, ear infection,
urinary tract infection, sexually transmitted infection, and others), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, branded and generic are the major segments of
cephalosporin market by type. Lucintel forecasts that generic is expected to
witness the higher growth over the forecast period as it is relatively cheaper
than branded medicine.
Within this market, third-generation cephalosporin is expected to witness
the highest growth as it is employed in the treatment of infectious disease.
Download sample by clicking on cephalosporin
market.
APAC will remain the largest region over the forecast period due to
elevated occurrence of infectious diseases and a surge in the demand for
cephalosporin.
Allergan, Bristol-Myers Squibb Company, F.Hoffmann-La Roche,
GlaxoSmithKline, Lupin Limited, Merck & Co, and Novartis International are
the major suppliers in the cephalosporin market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Supplementary
Cementitious Material Market in Canada
Thermochromic
Paint Market in Canada
No comments:
Post a Comment